Related Experiment Video
Updated: Dec 30, 2025

06:23
Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
Published on: August 4, 2018
9.1K
Coagulation Assessment in the Equine Patient
SallyAnne L DeNotta1, Marjory B Brooks2
1Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, 2015 Southwest 16th Avenue, Gainesville, FL 32608, USA.
The Veterinary Clinics of North America. Equine Practice
|January 29, 2020
Summary
Horses experiencing excessive bleeding require evaluation for hemostatic disorders. This review covers diagnostic tests and common coagulation problems in horses.
Area of Science:
- Veterinary Medicine
- Hematology
- Equine Health
Background:
- Unprovoked or excessive hemorrhage in horses can indicate underlying hemostatic defects.
- Platelet dysfunction and coagulopathies are potential causes of bleeding disorders.
Purpose of the Study:
- To provide an overview of diagnostic approaches for hemostatic defects in horses.
- To review common hemostatic disorders encountered in equine clinical practice.
Main Methods:
- Discussion of preliminary screening tests for coagulation.
- Outline of definitive diagnostic assays for assessing hemostasis.
- Review of clinical literature on equine hemostatic disorders.
Main Results:
- Comprehensive evaluation involves both screening and definitive coagulation tests.
- Identification of specific platelet defects and coagulopathies is crucial.
- Common hemostatic disorders in horses are presented.
Conclusions:
- Prompt evaluation of bleeding horses is essential for accurate diagnosis.
- Appropriate diagnostic testing aids in identifying the cause of hemorrhage.
- Understanding common hemostatic disorders improves clinical management of horses.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
157
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
157
Coagulation
9.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.4K
Coagulation
1.1K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.5K
Extrinsic and Intrinsic Pathways of Hemostasis
11.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.5K
Introduction to Hemostasis
12.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
12.7K

